Lurasidone

ADVERTISEMENT

Identification

Molecular formula
C28H36ClN3O2
CAS Number
367514-87-2
IUPAC Name
1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methyl-piperazin-4-ium;4-hydroxy-4-oxo-but-2-enoate
Molecular Weight
492.57g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2685g/cm3
Interesting facts

Interesting Facts About 1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methyl-piperazin-4-ium; 4-hydroxy-4-oxo-but-2-enoate

This compound presents a fascinating intersection of chemical structure and potential applications, particularly in the field of medicinal chemistry. Here are some noteworthy points:

  • Complex Structure: The compound features a unique fusion of a chlorobenzo[b][1]benzoxepin moiety and a piperazin-4-ium structure, which contributes to its diverse chemical behavior. The presence of both aromatic and heterocyclic components enhances its interactiveness with biological targets.
  • Biological Activity: Compounds like this one, characterized by their piperazine and benzoxepin units, have been studied for their potential in pharmaceutical applications. They may exhibit activity against various neurological disorders and demonstrate anti-inflammatory properties.
  • Importance of Functional Groups: The incorporation of the 4-hydroxy-4-oxo-but-2-enoate group is vital. This moiety may contribute to the compound's ability to participate in biological interactions and enhance its solubility, making it actionable in drug formulations.
  • Structure-Activity Relationship (SAR): In medicinal chemistry, the design and modification of compounds like this one are guided by SAR studies. By tweaking the chemical structure, researchers can optimize efficacy and minimize side effects, leading to safer and more effective therapeutic agents.
  • Research and Development: Such compounds are at the forefront of research, particularly in the context of developing new treatments for diseases where current medications have limitations. The exploration of its pharmacokinetics and toxicity will be essential steps in the development process.

In summary, the compound 1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methyl-piperazin-4-ium; 4-hydroxy-4-oxo-but-2-enoate is not just a molecule but a gateway to exploring new therapeutic landscapes. As scientific inquiry into its properties deepens, it holds the promise of contributing significantly to advancements in pharmacology.

ADVERTISEMENT